Hao Wang

Also affiliated with Guiyang Medical University, Yan'an University, Affiliated Hospital of Guizhou Medical University, Guizhou Provincial People's Hospital, University of Baltimore

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target”.

KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target

Science Immunology(2021)10.1126/sciimmunol.abf9792

N/A

2.5DataRank · unranked

89 citations

Xiaoxin Ren, Phillip M. Galbo, Scott Moerdler, Hao Wang, R. Alejandro Sica +11 more

TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells

Nature Communications(2024)10.1038/s41467-023-43843-6

N/A

0.614DataRank · unranked

59 citations

R. Alejandro Sica, Gurbakhash Kaur, Phillip M. Galbo, Zhixin Jing, Christopher Nishimura +8 more

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity

Journal of Clinical Investigation(2022)10.1172/jci163620

N/A

0DataRank · unranked

54 citations

Mou Peng, Xing Peng, Wei Yao, Phillip M. Galbo, Devin T. Corrigan +10 more

Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies

Blood(2023)10.1182/blood.2023022882

N/A

0DataRank · unranked

21 citations

Byong H. Kang, Oleksandr Kyrysyuk, Shiwei Zheng, Hao Wang, Nathan D. Mathewson +9 more